Current state and perspectives of CAR T cell therapy in central nervous system diseases - Takeaways - MDSpire

Current state and perspectives of CAR T cell therapy in central nervous system diseases

  • By

  • Lena Kristina Pfeffer

  • Felix Fischbach

  • Christoph Heesen

  • Manuel A Friese

  • November 12, 2024

  • 0 min

Share

  • 1

    CAR T cell therapy has transformed treatment for hematological malignancies and is expanding to include CNS disorders.

  • 2

    Therapy-refractoriness in CNS disorders is a challenge due to limited access and disease heterogeneity.

  • 3

    Initial applications of CAR T cells in multiple sclerosis and neuromyelitis optica show promising therapeutic outcomes.

  • 4

    CAR T cells' ability to penetrate CNS tissue offers potential for treating gliomas and neurodegenerative diseases.

  • 5

    Further mechanistic research and controlled trials are essential to optimize CAR T cell therapy for CNS diseases.

Original Source(s)

Current state and perspectives of CAR T cell therapy in central nervous system diseases

  • by Lena Kristina Pfeffer, Felix Fischbach, Christoph Heesen, Manuel A Friese

  • November 12, 2024

Related Content

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

  • by

  • March 4, 2026

  • 2 min
Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

  • by

  • April 6, 2026

  • 3 min
A network meta-analysis of the performance of acupoint stimulation therapy in improving fatigue, neurological function, and activities of daily living in patients with multiple sclerosis